SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-105010
Filing Date
2023-04-18
Accepted
2023-04-18 16:15:50
Documents
1
Group Members
ATHYRIUM FUNDS GP HOLDINGS LLCATHYRIUM GP HOLDINGS LLCATHYRIUM OPPORTUNITIES ASSOCIATES II LPATHYRIUM OPPORTUNITIES ASSOCIATES III GP LLCATHYRIUM OPPORTUNITIES ASSOCIATES III LPATHYRIUM OPPORTUNITIES II ACQUISITION 2 LPJEFFREY FERRELL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d499532dsc13ga.htm SC 13G/A 140689
  Complete submission text file 0001193125-23-105010.txt   142626
Mailing Address 45 MESPIL ROAD DUBLIN 4 L2 D04 W2F1
Business Address DEPT 920A, 196 HIGH ROAD WOOD GREEN LONDON X0 N22 8HH 353-1-518-0200
Amryt Pharma plc (Subject) CIK: 0001783010 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91925 | Film No.: 23827021
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities III Acquisition 2 LP (Filed by) CIK: 0001815268 (see all company filings)

IRS No.: 364883510 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A